Predictors of treatment failure 24 months after surgery for stress urinary incontinence
- PMID: 18206917
- PMCID: PMC2706575
- DOI: 10.1016/j.juro.2007.10.074
Predictors of treatment failure 24 months after surgery for stress urinary incontinence
Abstract
Purpose: We identified baseline demographic and clinical factors associated with treatment failure after surgical treatment of stress urinary incontinence.
Materials and methods: Data were obtained from 655 women randomized to Burch colposuspension or autologous rectus sling. Of those, 543 (83%) had stress failure status assessed at 24 months (269 Burch, 274 sling). Stress failure (261) was defined as self-report of stress urinary incontinence by the Medical, Epidemiological, and Social Aspects of Aging questionnaire, positive stress test or re-treatment for stress urinary incontinence. Nonstress failure (66) was defined as positive 24-hour pad test (more than 15 ml) or any incontinent episodes by 3-day voiding diary with none of the 3 criteria for stress failure. Subjects not meeting any failure criteria were considered a treatment success (185). Adjusting for surgical treatment group and clinical site, logistic regression models were developed to predict the probability of treatment failure.
Results: Severity of urge incontinence symptoms (p = 0.041), prolapse stage (p = 0.013), and being postmenopausal without hormone therapy (p = 0.023) were significant predictors for stress failure. Odds of nonstress failure quadrupled for every 10-point increase in Medical, Epidemiological, and Social Aspects of Aging questionnaire urge score (OR 3.93 CI 1.45, 10.65) and decreased more than 2 times for every 10-point increase in stress score (OR 0.36, CI 0.16, 0.84). The associations of risk factors and failure remained similar regardless of surgical group.
Conclusions: Two years after surgery, risk factors for stress failure are similar after Burch and sling procedures and include greater baseline urge incontinence symptoms, more advanced prolapse, and menopausal not on hormone replacement therapy. Higher urge scores predicted failure by nonstress specific outcomes.
References
-
- Sand PK, Bowen LW, Ostergard DR, Nakanishi AM. Hysterectomy and prior incontinence surgery as risk factors for failed retropubic cystourethropexy. JRM. 1988;33:171. - PubMed
-
- Salin A, Conquy S, Elie C, Touboul C, Parra J, Zerbib M, et al. Identification of risk factors for voiding dysfunction following TVT placement. European Urology. 2007;51:782. - PubMed
-
- Meschia M, Pifarotti P, Gate U, Bertozzi R. Tension-free vaginal tape: analysis of risk factors for failure. Int Urogynecol J. 2007;18:419. - PubMed
-
- Bowen LW, Sand PK, Ostergard DR, Franti CE. Unsuccessful Burch retropubic urethropexy: A case-controlled urodynamic study. Am J Obstet Gynecol. 1989;160:452. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK058234/DK/NIDDK NIH HHS/United States
- U01 DK58234/DK/NIDDK NIH HHS/United States
- U01 DK060393/DK/NIDDK NIH HHS/United States
- U01 DK60379/DK/NIDDK NIH HHS/United States
- U01 DK060380/DK/NIDDK NIH HHS/United States
- U01 DK060397/DK/NIDDK NIH HHS/United States
- K24 DK068389/DK/NIDDK NIH HHS/United States
- U01 DK60380/DK/NIDDK NIH HHS/United States
- U01 DK60395/DK/NIDDK NIH HHS/United States
- U01 DK060401/DK/NIDDK NIH HHS/United States
- U01 DK060395/DK/NIDDK NIH HHS/United States
- U01 DK58229/DK/NIDDK NIH HHS/United States
- U01 DK60397/DK/NIDDK NIH HHS/United States
- U01 DK58231/DK/NIDDK NIH HHS/United States
- U01 DK60393/DK/NIDDK NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- U01 DK060379/DK/NIDDK NIH HHS/United States
- U01 DK60401/DK/NIDDK NIH HHS/United States
- U01 DK058229/DK/NIDDK NIH HHS/United States
- U01 DK58225/DK/NIDDK NIH HHS/United States
- U01 DK058225/DK/NIDDK NIH HHS/United States
- U01 DK058231/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical